mhurhangee/patent-ind-claim-en huggingface dataset:
An apparatus comprising: a 2x1 fusion coupler ; an input/output optical fiber connected to the 2x1 fusion coupler; a detector optical subassembly fiber connected to the 2x1 fusion coupler; a laser optical subassembly fiber connected to the 2x1 fusion coupler; a transceiver comprising a transceiver electronic circuit printed wiring board , a laser optical subassembly electrically coupled to the transceiver electronic circuit printed wiring board and a detector optical subassembly electrically coupled to the transceiver electronic circuit printed wiring board, wherein the laser optical subassembly comprises a laser that is situated to transmit light to the laser optical subassembly fiber, and the detector optical subassembly comprises a photodetector that is situated to receive light from the detector optical subassembly fiber; wherein the apparatus further comprises a metal base ; characterized in that the 2x1 fusion coupler is disposed between the metal base and the transceiver electronic circuit printed wiring board, wherein the laser and detector optical subassemblies, the transceiver electronic circuit printed wiring board and the 2x1 fusion coupler are attached to the metal base. a 2x1 fusion coupler ; an input/output optical fiber connected to the 2x1 fusion coupler; a detector optical subassembly fiber connected to the 2x1 fusion coupler; a laser optical subassembly fiber connected to the 2x1 fusion coupler; a transceiver comprising a transceiver electronic circuit printed wiring board , a laser optical subassembly electrically coupled to the transceiver electronic circuit printed wiring board and a detector optical subassembly electrically coupled to the transceiver electronic circuit printed wiring board, wherein the laser optical subassembly comprises a laser that is situated to transmit light to the laser optical subassembly fiber, and the detector optical subassembly comprises a photodetector that is situated to receive light from the detector optical subassembly fiber; wherein the apparatus further comprises a metal base ; characterized in that the 2x1 fusion coupler is disposed between the metal base and the transceiver electronic circuit printed wiring board, wherein the laser and detector optical subassemblies, the transceiver electronic circuit printed wiring board and the 2x1 fusion coupler are attached to the metal base.
A clutch mechanism for use in a rotary power tool having a motor , the clutch mechanism comprising: an input member to which torque from the motor is transferred; an output member co-rotatable with the input member , the output member defining a rotational axis ; a cam surface formed on one of the input member or the output member ; a compression spring carried by the other of the input member or the output member for co-rotation therewith; and a follower having a circular cross-sectional shape biased against the cam surface by the compression spring , such that the cam surface applies a normal force to the follower ; wherein in response to the output member co-rotating with the input member , the normal force applied to the follower is along a line of action that is coaxial or parallel with the spring and does not intersect the rotational axis , and wherein, in response to relative rotation between the input member and the output member , the cam surface displaces the follower along the line of action ; characterised in that the line of action is transverse to the rotational axis . an input member to which torque from the motor is transferred; an output member co-rotatable with the input member , the output member defining a rotational axis ; a cam surface formed on one of the input member or the output member ; a compression spring carried by the other of the input member or the output member for co-rotation therewith; and a follower having a circular cross-sectional shape biased against the cam surface by the compression spring , such that the cam surface applies a normal force to the follower ; wherein in response to the output member co-rotating with the input member , the normal force applied to the follower is along a line of action that is coaxial or parallel with the spring and does not intersect the rotational axis , and wherein, in response to relative rotation between the input member and the output member , the cam surface displaces the follower along the line of action ; characterised in that the line of action is transverse to the rotational axis .
Method for battery management, in which a state of charge of at least one battery is detected by measurement and in which the state of charge of the at least one battery can be changed by a control unit and in which the charging voltages of the individual batteries of a plurality of batteries connected in series relative to one another are equalized by changing the at least one state of charge, wherein data transmission is carried out using near-field communication, NFC and a storage of recorded data for a period of about ten years in a long-term memory is carried out and wherein a galvanic isolation of a plurality of modules is carried out and wherein a discharge curve of the battery is kept ready in a short-term memory and wherein the battery data is analyzed after a discharge and recharge, wherein the measured data is recorded in addition to the non-erasable long-term memory with a high temporal resolution every second in a fast memory and the measurement results are displayed using a smartphone and wherein a capacity of the battery is measured and monitored.
Bend-nesting tool of bottlenecks, including: - a matrix forming, on one edge , a supporting surface of the outlet(s); - a moving blade with a contact surface of one of the embouti edges intended to be moved along the support surface of the matrix in order to bend that edge; - a gage intended to be mounted on the blade for the positioning of the said blade in relation to the supporting surface of the matrix , the gage comprising: - a first hold (112 1 ) configured to extend along the contact surface of the blade and to contact the support surface when moving the blade along the support surface of the matrix in the absence of the clutch(s), and - a second hold (112 2 ) configured to contact a lateral surface of the edge of the matrix , characterized that the second hold (112 2 ) is located, following the direction of movement of the moving blade , at the front of the first hold (112 1 ). - a matrix forming, on one edge , a supporting surface of the outlet(s); - a moving blade with a contact surface of one of the embouti edges intended to be moved along the support surface of the matrix in order to bend that edge; - a gage intended to be mounted on the blade for the positioning of the said blade in relation to the supporting surface of the matrix , the gage comprising: - a first hold (112 1 ) configured to extend along the contact surface of the blade and to contact the support surface when moving the blade along the support surface of the matrix in the absence of the clutch(s), and - a second hold (112 2 ) configured to contact a lateral surface of the edge of the matrix , characterized that the second hold (112 2 ) is located, following the direction of movement of the moving blade , at the front of the first hold (112 1 ).
A method for determining the prognosis of an individual having cancer and currently being treated with one or more immune checkpoint inhibitors, the method comprising or consisting of the steps of: a) providing a sample obtained from the individual prior to treatment with one or more immune checkpoint inhibitors; b) measuring the activity and/or concentration of thymidine kinase (TK) in the sample; c) providing a sample obtained from the individual 1-4 weeks after first treatment with the one or more immune checkpoint inhibitors; and d) measuring the activity and/or concentration of thymidine kinase (TK) in the sample provided in step (c); wherein the activity and/or concentration of thymidine kinase (TK) measured in steps (b) and (d) is indicative of the prognosis of the individual if further treated with one or more immune checkpoint inhibitors, wherein the prognosis of the individual if further treated with one or more checkpoint inhibitors is positive when the activity and/or concentration of thymidine kinase (TK) measured in step (d) is increased compared to the activity and/or concentration of thymidine kinase (TK) measured in step (b). a) providing a sample obtained from the individual prior to treatment with one or more immune checkpoint inhibitors; b) measuring the activity and/or concentration of thymidine kinase (TK) in the sample; c) providing a sample obtained from the individual 1-4 weeks after first treatment with the one or more immune checkpoint inhibitors; and d) measuring the activity and/or concentration of thymidine kinase (TK) in the sample provided in step (c);
Horizontal bar for the forming and filling head of a machine for forming and filling containers from preforms , comprising a drive unit for the axial movement of the horizontal bar , wherein at least the part of the drive unit connected to the horizontal bar is arranged in a drive chamber , which is sealed against the areas of the forming and filling head that come into contact with the filling material, characterized in that the sealing is carried out by a seal enclosing the horizontal bar , wherein the horizontal bar is axially movable relative to the seal and can be moved to a position in which it is not in contact with the seal for a cleaning operation, wherein the horizontal bar either has a circumferential groove in an area that does not come into contact with the seal during the stretching process, or the horizontal bar can be moved upwards for cleaning to the extent that it is moved out of the seal, or the seal enclosing the horizontal bar is a pressure-resistant seal on one side.
Apparatus for producing an object by means of additive manufacturing, comprising: - a process chamber for receiving on a build surface of a build plate a bath of powdered material which can be solidified; - a support for positioning said build plate in relation to a surface level of said bath of powdered material; - a solidifying device for solidifying a selective part of said material; and - a homing device for moving said build surface , by said support , to a home position such that said object can be build on said build surface of said build plate , wherein said homing device comprises a homing member which can be displaced along said build surface of said build plate , wherein said homing device is designed for moving said build surface to said home position until a measured force for displacing said homing member is within a pre-determined range, characterised in that said homing member is formed by a recoating device, such as a wiper, which can be displaced along the surface of the bath of powdered for levelling the surface of the bath and along the build surface of the build plate . - a process chamber for receiving on a build surface of a build plate a bath of powdered material which can be solidified; - a support for positioning said build plate in relation to a surface level of said bath of powdered material; - a solidifying device for solidifying a selective part of said material; and - a homing device for moving said build surface , by said support , to a home position such that said object can be build on said build surface of said build plate , wherein said homing device comprises a homing member which can be displaced along said build surface of said build plate , wherein said homing device is designed for moving said build surface to said home position until a measured force for displacing said homing member is within a pre-determined range, characterised in that said homing member is formed by a recoating device, such as a wiper, which can be displaced along the surface of the bath of powdered for levelling the surface of the bath and along the build surface of the build plate .
A pharmaceutical composition comprising a 1-methyl-pseudouridine-modified mRNA encoding a polypeptide of interest, wherein the mRNA is formulated as a lipid nanoparticle.
A method for measuring the transdermal emission of H 2 S through the skin of a human subject, comprising a) sealably mounting multiple dermal sampling strips on the skin in different areas of the subject's body, wherein each dermal sampling strip includes a sample collection chamber that comprises (i) a skin contact side that is in contact with the skin when the dermal sampling strip is mounted and (ii) one or more walls, the skin contact side and the wall(s) together defining a vapor space for collecting transdermally emitted gas, wherein the skin contact side has one or more openings which create one or more fluid paths between the skin and the vapor space for collecting the transdermally emitted gas; b) collecting the transdermally emitted gas in the sample collection chamber of the dermal sampling strips; and c) separately analyzing for the presence of H 2 S in the transdermally emitted gas collected in the sample collection chamber of each of the dermal sampling strips by contacting the transdermally emitted gas with a working electrode of an electrocatalytic cell, and measuring an electrical signal created by a reaction of the H 2 S at the working electrode to obtain differential rates of emission of H 2 S in the transdermally emitted gases through the skin in the different areas of the subject's body. a) sealably mounting multiple dermal sampling strips on the skin in different areas of the subject's body, wherein each dermal sampling strip includes a sample collection chamber that comprises (i) a skin contact side that is in contact with the skin when the dermal sampling strip is mounted and (ii) one or more walls, the skin contact side and the wall(s) together defining a vapor space for collecting transdermally emitted gas, wherein the skin contact side has one or more openings which create one or more fluid paths between the skin and the vapor space for collecting the transdermally emitted gas; b) collecting the transdermally emitted gas in the sample collection chamber of the dermal sampling strips; and c) separately analyzing for the presence of H 2 S in the transdermally emitted gas collected in the sample collection chamber of each of the dermal sampling strips by contacting the transdermally emitted gas with a working electrode of an electrocatalytic cell, and measuring an electrical signal created by a reaction of the H 2 S at the working electrode to obtain differential rates of emission of H 2 S in the transdermally emitted gases through the skin in the different areas of the subject's body.
A method of providing a graft scaffold for cartilage repair, particularly in a human patient, comprising the steps of: - providing an aqueous solution of a gelling polysaccharide; - providing at least one of: ° particles and/or fibres and ° mammalian cells; - mixing said aqueous solution of a gelling polysaccharide, said particles and/or fibres, and/or said mammalian cells to obtain a printing mix; - depositing said printing mix in a three-dimensional form, wherein said gelling polysaccharide is gellan gum, acylated and/or sulfated gellan gum, and wherein said printing mix comprises 3% or 3.5% (w/v) of said gelling polysaccharide, and wherein said solution of a gelling polysaccharide further comprises alginate. - providing an aqueous solution of a gelling polysaccharide; - providing at least one of: ° particles and/or fibres and ° mammalian cells; ° particles and/or fibres and ° mammalian cells; - mixing said aqueous solution of a gelling polysaccharide, said particles and/or fibres, and/or said mammalian cells to obtain a printing mix; - depositing said printing mix in a three-dimensional form,
A thermal flowmeter which includes: - a sub-passage taking a part of a measurement object gas flowing in a main passage , and - a flow measurement element measuring a flow amount of the measurement object gas flowing in the sub-passage and measures a flow amount of the measurement object gas flowing in the main passage on the basis of a measurement value obtained by the flow measurement element, wherein the sub-passage includes: - a curved passage which is bent toward the flow measurement element so that the measurement object gas taken from the main passage flows to the flow measurement element, and wherein the curved passage is provided with a resistance portion which applies a resistance to a flow of the measurement object gas flowing at an outer peripheral side of the curved passage so that pressure loss of the measurement object gas flowing at the outer peripheral side of the curved passage becomes higher than that of an inner peripheral side of the curved passage , wherein the resistance portion is formed as a pair of opposite inclined faces (52a, 52b; 52a', 52b') which is formed at an outer peripheral wall face of the outer peripheral side of the curved passage along a flow direction of the measurement object gas so that the resistance is applied to the flow of the measurement object gas flowing at the outer peripheral side, and wherein each of the inclined faces (52a, 52b; 52a', 52b') is inclined with respect to a virtual plane following a measurement front face of the flow measurement element, characterized in that : a gap is formed between the pair of opposite inclined faces (52a, 52b; 52a', 52b') in the same direction as the extension direction of the virtual plane. - a sub-passage taking a part of a measurement object gas flowing in a main passage , and - a flow measurement element measuring a flow amount of the measurement object gas flowing in the sub-passage and measures a flow amount of the measurement object gas flowing in the main passage on the basis of a measurement value obtained by the flow measurement element, wherein - a curved passage which is bent toward the flow measurement element so that the measurement object gas taken from the main passage flows to the flow measurement element, and wherein
A method of radio bearer transmission in dual connectivity for an evolved nodeB, eNB, in a long term evolution, LTE, system, the method comprising: determining a RB type for transmitting the RB to a mobile device, wherein the RB type includes a split RB which is transmitted by resources of both the eNB and a wireless local area network access point, WLAN AP, an assisted RB which is transmitted by resource of the WLAN AP, or a normal RB which is transmitted by resource of the eNB; transmitting a RB type change indication indicating the split RB, the assisted RB, or the normal RB of the determined RB type, to the mobile device; according to the determined RB type, generating at least a packet data convergence protocol protocol data unit, PDCP PDU, by a PDCP entity of the eNB corresponding to a radio bearer, RB, ; assigning each PDCP PDU to be transmitted to the WLAN AP with an identity, wherein the identity indicates which PDCP entity the PDCP PDU belongs to ; transmitting the PDCP PDU with the identity to the WLAN AP; receiving a private AP configuration indicating a configuration for a PDCP PDU transmission, from the WLAN AP, wherein the private AP configuration includes at least one of a private SSID, central frequency and/or bandwidth for the mobile device, security information for association, and IP address of the mobile device and time pattern, wherein the private AP configuration is received within an AP Resource Acknowledgement; and transmitting the private AP configuration to the mobile device to enable the mobile device to perform PDCP PDU reception from the WLAN AP according to the private AP configuration. determining a RB type for transmitting the RB to a mobile device, wherein the RB type includes a split RB which is transmitted by resources of both the eNB and a wireless local area network access point, WLAN AP, an assisted RB which is transmitted by resource of the WLAN AP, or a normal RB which is transmitted by resource of the eNB; transmitting a RB type change indication indicating the split RB, the assisted RB, or the normal RB of the determined RB type, to the mobile device; according to the determined RB type, generating at least a packet data convergence protocol protocol data unit, PDCP PDU, by a PDCP entity of the eNB corresponding to a radio bearer, RB, ; assigning each PDCP PDU to be transmitted to the WLAN AP with an identity, wherein the identity indicates which PDCP entity the PDCP PDU belongs to ; transmitting the PDCP PDU with the identity to the WLAN AP; receiving a private AP configuration indicating a configuration for a PDCP PDU transmission, from the WLAN AP, wherein the private AP configuration includes at least one of a private SSID, central frequency and/or bandwidth for the mobile device, security information for association, and IP address of the mobile device and time pattern, wherein the private AP configuration is received within an AP Resource Acknowledgement; and transmitting the private AP configuration to the mobile device to enable the mobile device to perform PDCP PDU reception from the WLAN AP according to the private AP configuration.
Inkjet printing process on a substrate comprising (a)a step of deposition of a self-assembled monolayer (SAM) on the substrate; (b)a step of printing of a material within the boundaries of the SAM, the material being a composition containing PZT (Pb(Zr,Ti)O 3 ), PLZT ((Pb,La)(Zr,Ti)O 3 ), PbTiO 3 , PbZrO 3 , Pb(Mg,Nb,Ti)O 3 , BaTiO 3 , or (Ba,Ca)(Ti,Zr)O 3 ; wherein both steps are made by inkjet printing. (a)a step of deposition of a self-assembled monolayer (SAM) on the substrate; (b)a step of printing of a material within the boundaries of the SAM, the material being a composition containing PZT (Pb(Zr,Ti)O 3 ), PLZT ((Pb,La)(Zr,Ti)O 3 ), PbTiO 3 , PbZrO 3 , Pb(Mg,Nb,Ti)O 3 , BaTiO 3 , or (Ba,Ca)(Ti,Zr)O 3 ; wherein both steps are made by inkjet printing.
A pharmaceutical preparation, comprising: an active ingredient and a release-controlling agent for controlling release of the active ingredient, and further comprising: a binder, an antioxidant, and a lubricant, wherein the active ingredient is at least one selected from among mirabegron and a pharmaceutically acceptable salt thereof, the release-controlling agent comprises a hydrogel-forming polymer alone, the active ingredient is contained in an amount of 5 to 28 wt%, the release-controlling agent is contained in an amount of 60 to 90 wt%, the binder is contained in an amount of 1 to 5 wt%, the antioxidant is contained in an amount of 0.1 to 1 wt%, and the lubricant is contained in an amount of 1 to 6 wt%, wherein the hydrogel-forming polymer is polyethylene oxide and has an average molecular weight ranging from 100,000 to less than 1,000,000. a binder, an antioxidant, and a lubricant, wherein the active ingredient is at least one selected from among mirabegron and a pharmaceutically acceptable salt thereof, the release-controlling agent comprises a hydrogel-forming polymer alone, the active ingredient is contained in an amount of 5 to 28 wt%, the release-controlling agent is contained in an amount of 60 to 90 wt%, the binder is contained in an amount of 1 to 5 wt%, the antioxidant is contained in an amount of 0.1 to 1 wt%, and the lubricant is contained in an amount of 1 to 6 wt%, wherein the hydrogel-forming polymer is polyethylene oxide and has an average molecular weight ranging from 100,000 to less than 1,000,000.